Transcarent Funding History

Since Transcarent was founded in 2020, it has participated in 4 rounds of funding. In total Transcarent has raised $424.0M. Transcarent's last funding round was on May 2024 for a total of $126.0M.

Transcarent Funding Rounds

Series D

May 2024

$126M

General Catalyst, 7wireVentures, Geodesic Capital, Memorial Hermann Health System, Threshold Ventures, Kinnevik, Ally Bridge Group, Human Capital, Merck Global Health Innovation Fund, Alta Partners, Ally Bridge Group, Leaps by Bayer

Series C

Jan 2022

$200M

Kinnevik, Human Capital, Ally Bridge Group, Northwell Health, Intermountain Healthcare, Rush University Medical Center, General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund, Threshold Ventures, GreatPoint Ventures

Series B

Jun 2021

$58M

General Catalyst, 7wireVentures, Merck Global Health Innovation Fund, Kleiner Perkins, Leaps by Bayer, GreatPoint Ventures, Threshold Ventures, Alta Partners

Series A

Oct 2020

$40M

7wireVentures, Alta Partners, General Catalyst

Transcarent Investors

General Catalyst

Series D, Series C, Series B, Series A

May 2024, Jan 2022, Jun 2021, Oct 2020

7wireVentures

Series D, Series C, Series B, Series A

May 2024, Jan 2022, Jun 2021, Oct 2020

Geodesic Capital

Series D

May 2024

Memorial Hermann Health System

Series D

May 2024

Threshold Ventures

Series D, Series C, Series B

May 2024, Jan 2022, Jun 2021

Transcarent has 16 investors, including General Catalyst, 7wireVentures and Geodesic Capital. The latest investment occurred in May 2024.

Transcarent Funding History

Since Transcarent was founded in 2020, it has participated in 4 rounds of funding. In total Transcarent has raised $424.0M. Transcarent's last funding round was on May 2024 for a total of $126.0M.

Transcarent Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Total Funding: $424M

Transcarent Investors

INVESTOR

ROUND

FUNDING DATE

Total Investors: 16